MRSA Testing Market size to grow by USD 682.12 million from 2022 to 2027, Driven by the rising staphylococcal infections- Technavio

USA - English

• USA - English

NEW YORK, March 27, 2023 /PRNewswire/ -- The MRSA testing market is estimated to grow by USD 682.12 million from 2022 to 2027. The market will be growing at a CAGR of 12.13% during the forecast period. The increasing incidence of staphylococcal infections significantly drives the market growth, although factors such as the shortage of trained professionals may impede the market growth. For comprehensive details on the market size of the historic period(2017 to 2021) and forecast period (2023-2027) - View Sample report

What's New? -

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy the report!

Vendor Landscape
The MRSA testing market is fragmented; the vendors are competing with competitors and are trying to get a greater market share. The major vendors have well-established economies of scale and market presence and generally rely on positioning, technological advances, and the price of the products - The report provides a full list of key vendors, their strategies, and the latest developments.

Company Profiles

The MRSA testing market report includes information on the product launches, sustainability, and prospects of leading vendors, including 3M Co., Abbott Laboratories, ALIFAX Srl, Arlington Scientific Inc., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Bruker Corp., Creative Diagnostics, Danaher Corp., DiaSorin Spa, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GENSPEED Biotech GmbH, OpGen Inc., Puritan Medical Products Co., R Biopharm AG, Sekisui Diagnostics LLC, Uniogen Oy, and ZeptoMetrix LLC.

Market Dynamics

Major Drivers & Challenges- 

The market is driven by factors such as the increasing incidence of staphylococcal infections, the introduction of new MRSA diagnostic tests, and the increased adoption of automation and system integration in healthcare. Risk factors related to ha-MRSA and ca-MRSA infections are hindering market growth. The rising incidence of staphylococcal infections is a major factor driving the growth of the global methicillin-resistant staphylococcus aureus (MRSA) testing market. This is because of the emergence of antibiotic-resistant staphylococcal strains, such as MRSA and VRSA. Most staphylococcal infections are known to develop in hospitals and other healthcare settings, such as dialysis centers and nursing homes, due to exposure to open body surfaces.

A shortage of trained professionals is a primary challenge to the growth of the global methicillin-resistant staphylococcus aureus (MRSA) testing market. The processes in MRSA testing require the accurate interpretation of results, and researchers must be aware of the analysis to be carried out and its correlation with the overall objective of the experiment. The adoption of critical experiments is relatively new in developing countries of APAC, Africa, and South America. Most laboratory technicians are not trained adequately on the latest technologies in laboratory equipment. Furthermore, there is a shortage of trained professionals who can handle technologically advanced diagnostic devices. 

Key Trends - 

The rise in the use of MRSA quick tests using lab-on-chip technology in hospital settings is the leading trend in the global methicillin-resistant staphylococcus aureus (MRSA) testing market growth. Patients admitted into hospitals are tested for MRSA bacteria, whereas conventional laboratory sample testing takes more time to provide results. The lab-on-chip (LoC) is a small microfluidic component through which MRSA can be detected in one hour, which identifies the presence of the MRSA virus in nasal swabs at the time of admission into hospitals. Then, the sample is directly inserted into the LoC and placed in the analysis system. The isolation and treatment of the patient can be initiated immediately if tested positive.

Technavio has identified key trends, drivers, and challenges in the market, which will
help clients improve their strategies to stay ahead of their competitors - View Sample
Report

Competitive Analysis

The report includes competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others.

 Market Segmentation

In this Technavio report, the MRSA testing market report extensively covers market segmentation by end-user (hospitals and diagnostic laboratories and academic and research institutes), type (molecular diagnostics and immunodiagnostics), and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The market share growth by the hospital and diagnostic laboratories segment will be significant for the overall market growth during the forecast period. Hospitals and diagnostic laboratories are an integral part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs, and clinical research and diagnostic techniques enable prompt and early intervention, thereby reducing disease burden and promoting health. The data from patient samples are used to determine the medication required for MRSA. 

Geographic Analysis

In this report, the MRSA testing market report, the market is geographically divided into North America, Europe, Asia, and Rest of World (ROW).

• North America is estimated to contribute to 43% of the growth of the global market during the forecast period. The methicillin-resistant staphylococcus aureus testing market in the region is growing majorly due to the increasing demand for diagnostics such as HA-MRSA and CA-MRSA across different countries in North America. This has been brought about by the increased awareness among people to get diagnosed with MRSA infections. Most individuals in developed countries opt for these tests, increasing the sales of MRSA testing products in the market.

For insights on global, regional, and country-level parameters with growth opportunities
from 2017 to 2027 - Download a Sample Report

Related Reports - 

The food pathogen testing market size is expected to increase by USD 3 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.39%. The growing importance of food safety standards is one of the key factors driving the global food pathogen testing market growth.

The pneumonia testing market size is estimated to grow at a CAGR of 5.3% between 2022 and 2027. The size of the market is forecast to increase by USD 709 million. The rising prevalence of pneumonia and concerns associated with pneumonia mortality are notably driving the market research growth.

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Browse for Technavio Health Care market reports  

Table of Contents     

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global MRSA testing market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global MRSA testing market 2017 - 2021 ($ million)

• 4.2 End-user Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.3 Type Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user

• 6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)

• 6.4 Academic and research institutes - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by End-user 
• Exhibit 42: Market opportunity by End-user ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 43: Chart on Type - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Type - Market share 2022-2027 (%)

• 7.2 Comparison by Type
• Exhibit 45: Chart on Comparison by Type
• Exhibit 46: Data Table on Comparison by Type

• 7.3 Molecular diagnostics - Market size and forecast 2022-2027 
• Exhibit 47: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)

• 7.4 Immunodiagnostics - Market size and forecast 2022-2027 
• Exhibit 51: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Type 
• Exhibit 55: Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 57: Chart on Market share by geography 2022-2027 (%)
• Exhibit 58: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027 
• Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027 
• Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 Japan - Market size and forecast 2022-2027 
• Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.11 Canada - Market size and forecast 2022-2027 
• Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 97: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 98: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 99: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 100: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 101: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 102: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 103: Matrix on vendor position and classification

• 12.3 3M Co.
• Exhibit 104: 3M Co. - Overview
• Exhibit 105: 3M Co. - Business segments
• Exhibit 106: 3M Co. - Key offerings
• Exhibit 107: 3M Co. - Segment focus

• 12.4 Abbott Laboratories
• Exhibit 108: Abbott Laboratories - Overview
• Exhibit 109: Abbott Laboratories - Business segments
• Exhibit 110: Abbott Laboratories - Key news
• Exhibit 111: Abbott Laboratories - Key offerings
• Exhibit 112: Abbott Laboratories - Segment focus

• 12.5 Arlington Scientific Inc. 
• Exhibit 113: Arlington Scientific Inc. - Overview
• Exhibit 114: Arlington Scientific Inc. - Product / Service
• Exhibit 115: Arlington Scientific Inc. - Key offerings

• 12.6 Becton Dickinson and Co. 
• Exhibit 116: Becton Dickinson and Co. - Overview
• Exhibit 117: Becton Dickinson and Co. - Business segments
• Exhibit 118: Becton Dickinson and Co. - Key news
• Exhibit 119: Becton Dickinson and Co. - Key offerings
• Exhibit 120: Becton Dickinson and Co. - Segment focus

• 12.7 bioMerieux SA
• Exhibit 121: bioMerieux SA - Overview
• Exhibit 122: bioMerieux SA - Product / Service
• Exhibit 123: bioMerieux SA - Key offerings

• 12.8 Bio Rad Laboratories Inc. 
• Exhibit 124: Bio Rad Laboratories Inc. - Overview
• Exhibit 125: Bio Rad Laboratories Inc. - Business segments
• Exhibit 126: Bio Rad Laboratories Inc. - Key news
• Exhibit 127: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 128: Bio Rad Laboratories Inc. - Segment focus

• 12.9 Bruker Corp.
• Exhibit 129: Bruker Corp. - Overview
• Exhibit 130: Bruker Corp. - Business segments
• Exhibit 131: Bruker Corp. - Key news
• Exhibit 132: Bruker Corp. - Key offerings
• Exhibit 133: Bruker Corp. - Segment focus

• 12.10 Danaher Corp.
• Exhibit 134: Danaher Corp. - Overview
• Exhibit 135: Danaher Corp. - Business segments
• Exhibit 136: Danaher Corp. - Key news
• Exhibit 137: Danaher Corp. - Key offerings
• Exhibit 138: Danaher Corp. - Segment focus

• 12.11 DiaSorin Spa
• Exhibit 139: DiaSorin Spa - Overview
• Exhibit 140: DiaSorin Spa - Business segments
• Exhibit 141: DiaSorin Spa - Key offerings
• Exhibit 142: DiaSorin Spa - Segment focus

• 12.12 Eurofins Scientific SE 
• Exhibit 143: Eurofins Scientific SE - Overview
• Exhibit 144: Eurofins Scientific SE - Business segments
• Exhibit 145: Eurofins Scientific SE - Key news
• Exhibit 146: Eurofins Scientific SE - Key offerings
• Exhibit 147: Eurofins Scientific SE - Segment focus

• 12.13 F. Hoffmann La Roche Ltd. 
• Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus

• 12.14 GENSPEED Biotech GmbH 
• Exhibit 153: GENSPEED Biotech GmbH - Overview
• Exhibit 154: GENSPEED Biotech GmbH - Product / Service
• Exhibit 155: GENSPEED Biotech GmbH - Key offerings

• 12.15 OpGen Inc.
• Exhibit 156: OpGen Inc. - Overview
• Exhibit 157: OpGen Inc. - Product / Service
• Exhibit 158: OpGen Inc. - Key offerings

• 12.16 Puritan Medical Products Co. 
• Exhibit 159: Puritan Medical Products Co. - Overview
• Exhibit 160: Puritan Medical Products Co. - Product / Service
• Exhibit 161: Puritan Medical Products Co. - Key offerings

• 12.17 Uniogen Oy
• Exhibit 162: Uniogen Oy - Overview
• Exhibit 163: Uniogen Oy - Product / Service
• Exhibit 164: Uniogen Oy - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 165: Inclusions checklist
• Exhibit 166: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 167: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 168: Research methodology
• Exhibit 169: Validation techniques employed for market sizing
• Exhibit 170: Information sources

• 13.5 List of abbreviations 
• Exhibit 171: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio